Skip to main content
 logotype

Main navigation (without target group)

  • CONTACT
  • CHOOSE LANGUAGE

The information on this website is intended for patients in the European Union (EU) who have been prescribed Alprolix®

БЪЛГАРСКИ (BG)

ČEŠTINA (CS)

DANSK (DA)

DEUTSCH (DE)

ΕΛΛΗΝΙΚΆ (EL)

ENGLISH (EN)

ESPAÑOL (ES)

EESTI KEEL (ET)

SUOMI (FI)

FRANÇAIS (FR)

HRVATSKI (HR)

MAGYAR (HU)

ISLENSKA (IS)

ITALIANO (IT)

LIETUVIŲ KALBA (LT)

LATVIEŠU VALODA (LV)

NEDERLANDS (NL)

NORSK (NO)

POLSKI (PL)

PORTUGUÊS (PT)

ROMÂNĂ (RO)

SLOVENČINA (SK)

SLOVENŠČINA (SL)

SVENSKA (SV)

Footer Menu

  • Cookie Policy
  • Privacy Policy
  • Terms of Use
sobi

Marketing Authorisation Holder:

Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, Sweden
Phone:  +46 8 697 20 00
Reg.No. 556038-9321 

Website updated: 2024-11-01